Our study demonstrated that LBPs exert an anti-hyperuricaemia effect by increasing theexpression of renal OAT1 and OAT3, decreasing the expression of renal GLUT9, and inhibitingXOD activity. Here, SLC22A8 is linked to hyperuricemia.